Posted by Michael Wonder on 25 May 2022
Medicare spending on drugs with accelerated approval
24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to be “reasonably likely” to predict clinical benefit.
To receive full approval, drugs must complete a confirmatory trial.
